A complex secondary structure in U1A pre‐mRNA that binds two molecules of U1A protein is required for regulation of polyadenylation.

CW van Gelder, SI Gunderson, EJ Jansen… - The EMBO …, 1993 - embopress.org
The human U1A protein‐U1A pre‐mRNA complex and the relationship between its structure
and function in inhibition of polyadenylation in vitro were investigated. Two molecules of …

Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration

…, A Tveit, SB Uittenbogaart, IC Van Gelder… - Circulation, 2017 - Am Heart Assoc
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first diagnosed
at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent …

Temporal relationship between subclinical atrial fibrillation and embolic events

…, A Capucci, C Muto, CP Lau, IC Van Gelder… - Circulation, 2014 - Am Heart Assoc
Background— Among patients with implantable pacemakers and defibrillators, subclinical
atrial fibrillation (SCAF) is associated with an increased risk of stroke; however, there is limited …

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

…, JH Svendsen, RM Touyz, IC Van Gelder… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines, …

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

IC Van Gelder, JS Healey, HJGM Crijns… - European heart …, 2017 - academic.oup.com
Background ASSERT demonstrated that subclinical atrial fibrillation (SCAF) is common in
pacemaker patients without prior AF and is associated with increased risk of ischemic stroke or …

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European …

…, F Ruschitzka, M Tendera, IC Van Gelder… - European heart …, 2013 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

[HTML][HTML] Subclinical atrial fibrillation and the risk of stroke

…, MR Gold, CW Israel, IC Van Gelder… - New England journal …, 2012 - Mass Medical Soc
Background One quarter of strokes are of unknown cause, and subclinical atrial fibrillation
may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial …

Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke

…, AP Benz, L Johnson, SJ Connolly, IC Van Gelder… - EP …, 2022 - academic.oup.com
Aims There is uncertainty about whether and how to perform screening for atrial fibrillation (AF).
To estimate the incidence of previously undetected AF that would be captured using a …

Relevance of electrical remodeling in human atrial fibrillation: results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial …

…, A Capucci, IC Van Gelder… - Circulation …, 2012 - Am Heart Assoc
Background— In animal models of atrial fibrillation (AF), changes in atrial electrophysiological
properties are associated with the development of AF. Their relevance to human AF is …

Ethnic differences in atrial fibrillation identified using implanted cardiac devices

…, SJ Connolly, IC Van Gelder… - Journal of …, 2013 - Wiley Online Library
Van Gelder received compensation for participation on a speaker's bureau and serves as
consultant/advisory board member for Boehringer Ingelheim, Bayer, and BMS/Pfizer; MR Gold …